Linda C. Meade-Tollin

Linda Celida Meade-Tollin (1944-) biochemist.

Background

Meade-Tollin was born in West Virginia, studying chemistry at West Virginia State College in 1964. Meade-Tollin worked at Harlem and Bellevue Hospitals before entering a chemistry PhD program at the City University of New York in 1972, transferring to biochemistry the following year, writing her doctoral thesis on gene expression in E. coli.

Meade-Tollin's first faculty appointment was at the College at Old Westbury, and acted as a visiting assistant professor at Rockefeller University, working on sickle cell anemia. Meade-Tollin received a National Institutes of Health postdoctoral award at the University of Arizona, where she was the only African-American woman to head a biomedical research laboratory at the University, and her research focused on DNA damage, angiogenesis, and cancer invasion and metastasis[1]. Meade-Tollin developed a new bioassay for angiogenesis in human microvascular endothelial cells, which was used to identify inhibitors and enhancers from desert fungi, and she spent a year as Faculty Development Fellow at Morehouse School of Medicine[2].

Awards

Meade-Tollin received of the Minority Investigator award from the National Cancer Institute in 1987 and 1990, and the Minority Investigator award from the National Heart Lung and Blood Institute in 1994.

References
  1. "Linda C Meade-Tollin". Loop Frontiers.
  2. African American women chemists. Oxford University Press. pp. 74–83. ISBN 9780199742882.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.